ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements with these filters
Medistep Healthcare Limited held its 3rd Annual General Meeting on September 17, 2026. Shareholders transacted on financial statements, director re-appointment, and investment thresholds.
Medistep Healthcare Limited has appointed M/s. Kapil Kumar Agarwal & Associates as Internal Auditor and M/s. Vaibhav Sharma & Associates as Secretarial Auditor.
Medistep Healthcare Limited announced the outcome of its board meeting held on August 24, 2026. Key decisions include notice for the AGM and appointment of auditors.
Medistep Healthcare Limited has issued a notice for its 3rd Annual General Meeting (AGM) to be held on September 17, 2026. The filing includes the company's annual report.
Medistep Healthcare is incorporating a wholly owned subsidiary, Genicus Healthcare Private Limited. The new entity will manufacture nutraceuticals and allopathic products in India.
Medistep Healthcare Ltd reported revenue from operations of ₹35.8 Cr (+26.1% YoY) and net profit of ₹3 Cr (+20.0% YoY) for H2 FY26.
Medistep Healthcare Limited reported a total income of ₹70.83 Crore for FY2026. The Board approved these audited standalone results alongside an unmodified auditor's opinion.
Medistep Healthcare scheduled a board meeting for May 26, 2026, to approve audited annual financial results. The trading window remains closed for designated persons.
Medistep Healthcare Limited submitted its annual compliance certificate for the Structured Digital Database (SDD) for the year ended March 31, 2026. The certificate, issued by a Practicing Company Secretary, confirms that the company maintains an internal, non-tamperable database to track UPSI events and access control.
Medistep Healthcare Limited has submitted a non-applicability declaration regarding Corporate Governance Report requirements for the quarter and year ended March 31, 2026. As an SME-listed entity, it is exempt under Regulation 15(2) of SEBI LODR. The company confirms it will ensure compliance if thresholds are met in the future.
Medistep Healthcare Limited informed the exchange that the Annual Secretarial Compliance Report for the year ended March 31, 2026, is not applicable. The company is claiming exemption under SEBI Regulation 15(2) as an entity listed on the SME Exchange.
Medistep Healthcare Limited informed the National Stock Exchange that it does not meet the criteria for classification as a 'Large Entity' for the financial year ended March 31, 2026. This disclosure follows SEBI's framework for fund raising via debt securities by large corporate entities.
Medistep Healthcare Limited's promoters submitted a yearly declaration under SEBI (SAST) Regulations for FY 2025-26. The promoters confirmed that no direct or indirect encumbrances were made on their shareholdings during the period. This is a routine regulatory compliance filing.